MGLIX
Price
$15.77
Change
+$0.13 (+0.83%)
Updated
Apr 24 closing price
Net Assets
2.19B
TGREX
Price
$11.69
Change
+$0.07 (+0.60%)
Updated
Apr 24 closing price
Net Assets
40.74M
Ad is loading...

MGLIX vs TGREX

Header iconMGLIX vs TGREX Comparison
Open Charts MGLIX vs TGREXBanner chart's image
MFS Global Real Estate I
Price$15.77
Change+$0.13 (+0.83%)
VolumeN/A
Net Assets2.19B
TCW Global Real Estate I
Price$11.69
Change+$0.07 (+0.60%)
VolumeN/A
Net Assets40.74M
MGLIX vs TGREX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MGLIX vs. TGREX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGLIX is a Buy and TGREX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
MGLIX has more cash in the bank: 2.19B vs. TGREX (40.7M). MGLIX pays higher dividends than TGREX: MGLIX (2.61) vs TGREX (2.00). MGLIX was incepted earlier than TGREX: MGLIX (16 years) vs TGREX (10 years). TGREX (1.34) is less costly to investors than MGLIX (0.95). TGREX is a more actively managed with annual turnover of: 71.48 vs. MGLIX (48.00). MGLIX has a lower initial minimum investment than TGREX: MGLIX (0) vs TGREX (2000). TGREX annual gain was more profitable for investors over the last year : 4.86 vs. MGLIX (2.35). TGREX return over 5 years is better than : 41.33 vs. MGLIX (21.58).
MGLIXTGREXMGLIX / TGREX
Total Expense Ratio0.940.90104%
Annual Report Gross Expense Ratio0.951.3471%
Fund Existence16 years10 years-
Gain YTD-2.4940.599-416%
Front LoadN/AN/A-
Min. Initial Investment02000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.19B40.7M5,381%
Annual Yield % from dividends2.612.00131%
Returns for 1 year2.354.8648%
Returns for 3 years-21.16-5.78366%
Returns for 5 years21.5841.3352%
Returns for 10 years19.2139.4249%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TOCQX43.02N/A
N/A
Tocqueville
JFNAX63.90N/A
N/A
Janus Henderson Global Life Sciences A
GMVRX14.37N/A
N/A
Goldman Sachs Small/Mid Cap Value R
NSFOX10.22N/A
N/A
Natixis Target Retirement 2065 N
GTDIX33.14N/A
N/A
Invesco EQV Emerging Markets All Cap R5